Evidence map›Paper›PMID 28496817›Full record

ReviewJournal of atrial fibrillation

Impact of Metabolic Syndrome on Ablation-Outcome in Patients with Atrial Fibrillation: A Systematic Review.

Sanghamitra Mohanty, Luigi Di Biase, Prasant Mohanty, Pasquale Santangeli, Bai Rong, Trivedy Chintan, David Burkhardt, Joseph G Gallinghouse, Rodney Horton, Javier E Sanchez and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of atrial fibrillation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Sanghamitra MohantySt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Luigi Di BiaseSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Prasant MohantySt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Pasquale SantangeliSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Bai RongSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Trivedy ChintanSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
David BurkhardtSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Joseph G GallinghouseSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Rodney HortonSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Javier E SanchezSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Shane BaileySt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Jason ZagrodzkySt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Andrea NataleSt. David?s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas.
Stanford University · USThe University of Texas at Austin · USHuazhong University of Science and Technology · CNUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-ablation by effectively addressing the different constituents of MS.

Identifiers

PMID28496817
PMCPMC5153112
OpenAlexW3022534063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.